LIFE-THREATENING THYROTOXICOSIS INDUCED BY COMBINATION THERAPY WITH PEG-INTERFERON AND RIBAVIRIN IN CHRONIC HEPATITIS C

Yong Q. Lin; Xiangbing Wang; Meena S. Murthy; Sumon Agarwala

doi:10.4158/ep.11.2.135

LIFE-THREATENING THYROTOXICOSIS INDUCED BY COMBINATION THERAPY WITH PEG-INTERFERON AND RIBAVIRIN IN CHRONIC HEPATITIS C

Endocrine Practice ◽

10.4158/ep.11.2.135 ◽

2005 ◽

Vol 11 (2) ◽

pp. 135-139 ◽

Cited By ~ 8

Author(s):

Yong Q. Lin ◽

Xiangbing Wang ◽

Meena S. Murthy ◽

Sumon Agarwala

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Life Threatening

Download Full-text

Which is the most cost-effective combination therapy strategy for naÃ¯ve patients with chronic hepatitis C?

Journal of Hepatology ◽

10.1016/s0168-8278(01)80592-4 ◽

2001 ◽

Vol 34 (0) ◽

pp. 162

Author(s):

M Buti

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Cost Effective ◽

Therapy Strategy ◽

Effective Combination

Download Full-text

Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response

The Korean Journal of Hepatology ◽

10.3350/kjhep.2009.15.3.338 ◽

2009 ◽

Vol 15 (3) ◽

pp. 338 ◽

Cited By ~ 11

Author(s):

Soung Won Jeong ◽

Jin Dong Kim ◽

Hyun Young Woo ◽

Chan Ran You ◽

Sung Won Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Chronic Hepatitis C Patients

Download Full-text

Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C

The Korean Journal of Hepatology ◽

10.3350/kjhep.2008.14.1.46 ◽

2008 ◽

Vol 14 (1) ◽

pp. 46 ◽

Cited By ~ 15

Author(s):

Heon Ju Lee ◽

Jong Ryul Eun ◽

Jae Won Choi ◽

Kyung Ok Kim ◽

Hee Jung Moon

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Treatment Duration ◽

Interferon Alpha 2B ◽

Therapeutic Results

Download Full-text

High Prevalence of Cutaneous Reactions to Interferon Alfa Plus Ribavirin Combination Therapy in Patients With Chronic Hepatitis C Virus

Archives of Dermatology ◽

10.1001/archderm.135.8.1000 ◽

1999 ◽

Vol 135 (8) ◽

pp. 1000-1001 ◽

Cited By ~ 57

Author(s):

S. Sookoian

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Interferon Alfa ◽

High Prevalence ◽

Chronic Hepatitis C Virus ◽

Cutaneous Reactions

Download Full-text

The Daclatasvir/Asunaprevir/Beclabuvir Combination Therapy for Chronic Hepatitis C Patients Experiencing Failure of IFN-Free DAA-Based Therapies

OBM Hepatology and Gastroenterology ◽

10.21926/obm.hg.1904041 ◽

2019 ◽

Vol 3 (4) ◽

pp. 1-1

Author(s):

Ken Sato ◽

◽

Atsushi Naganuma ◽

Shuichi Saito ◽

Yuichi Yamazaki ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Chronic Hepatitis C Patients

Download Full-text

Accordion Index: A new tool for the prediction of the efficacy of peg-interferon-α-2b and ribavirin combination therapy for chronic hepatitis C

Hepatology Research ◽

10.1111/j.1872-034x.2007.00272.x ◽

2008 ◽

Vol 38 (3) ◽

pp. 315-318 ◽

Cited By ~ 1

Author(s):

Takeaki Satoh ◽

Akihide Masumoto

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Interferon Α

Download Full-text

Prediction of sustained virologic responses to combination therapy of pegylated interferon-α and ribavirin in patients with chronic hepatitis C infection

Journal of Family and Community Medicine ◽

10.4103/2230-8229.108182 ◽

2013 ◽

Vol 20 (1) ◽

pp. 35 ◽

Cited By ~ 16

Author(s):

MonaH Ismail

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Α ◽

Hepatitis C Infection

Download Full-text

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?

Wiener klinische Wochenschrift ◽

10.1007/bf03217702 ◽

2004 ◽

Vol 116 (15-16) ◽

pp. 508-510

Author(s):

Wolfgang Vogel

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Interferon Α ◽

Chronic Hepatitis C Patients

Download Full-text

360 CXCL10 GENE POLYMORPHISM PREDICTS RAPID VIROLOGIC RESPONSE TO PEGYLATED INTERFERON/RIBAVIRIN COMBINATION THERAPY IN ASIAN PATIENTS WITH DIFFICULT-TO-TREAT CHRONIC HEPATITIS C GENOTYPE

Journal of Hepatology ◽

10.1016/s0168-8278(13)60362-1 ◽

2013 ◽

Vol 58 ◽

pp. S149

Author(s):

K. Thanapirom ◽

S. Suksawatamnuay ◽

P. Tangkijvanich ◽

S. Treeprasertsuk ◽

Y. Poovorawan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Gene Polymorphism ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Virologic Response ◽

Rapid Virologic Response ◽

Asian Patients

Download Full-text

Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease

Clinical and Experimental Nephrology ◽

10.1007/s10157-016-1348-7 ◽

2016 ◽

Vol 21 (5) ◽

pp. 818-824 ◽

Cited By ~ 5

Author(s):

Norihiko Morisawa ◽

Yohei Koshima ◽

Jun-ichi Satoh ◽

Yukio Maruyama ◽

Satoru Kuriyama ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Kidney Disease ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Chronic Hepatitis C Patients

Download Full-text